Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Baker Hughes A | BKR | Apr 24, 2024 | 32.67 | -1.00 |
Ball | BALL | Apr 24, 2024 | 65.19 | -0.47 |
Bank Of America | BAC | Apr 24, 2024 | 38.32 | -0.13 |
Bank Of New York Mellon | BK | Apr 24, 2024 | 57.95 | +0.89 |
Bath & Body Works | BBWI | Apr 24, 2024 | 45.60 | +1.04 |
Baxter International | BAX | Apr 24, 2024 | 40.93 | -0.22 |
Becton, Dickinson And Co | BDX | Apr 24, 2024 | 233.83 | -0.23 |
Berkshire Hathaway B | BRK-B | Apr 24, 2024 | 405.95 | -0.68 |
Best Buy | BBY | Apr 24, 2024 | 74.43 | -0.81 |
Bio-Rad Laboratories A | BIO | Apr 24, 2024 | 278.21 | -2.48 |
Bio-Techne | TECH | Apr 24, 2024 | 63.52 | -0.27 |
Biogen | BIIB | Apr 24, 2024 | 201.99 | +4.56 |
BlackRock | BLK | Apr 24, 2024 | 762.80 | -0.50 |
Blackstone | BX | Apr 24, 2024 | 123.78 | -0.43 |
Boeing | BA | Apr 24, 2024 | 164.33 | -2.87 |
Booking | BKNG | Apr 24, 2024 | 3 517.52 | -0.47 |
BorgWarner | BWA | Apr 24, 2024 | 33.65 | +0.93 |
Boston Properties | BXP | Apr 24, 2024 | 62.94 | +0.02 |
Boston Scientific | BSX | Apr 24, 2024 | 72.91 | +5.68 |
Bristol-Myers Squibb | BMY | Apr 24, 2024 | 48.86 | -0.27 |
Broadcom | AVGO | Apr 24, 2024 | 1 256.82 | +0.61 |
Broadridge Financial Solutions | BR | Apr 24, 2024 | 195.08 | -0.42 |
Brown & Brown | BRO | Apr 24, 2024 | 82.13 | -0.96 |
Brown Forman B | BF-B | Apr 24, 2024 | 49.01 | -0.77 |
Builders Firstsource | BLDR | Apr 24, 2024 | 186.69 | -0.29 |
Bunge | BG | Apr 24, 2024 | 105.79 | -3.49 |
C.H. Robinson Worldwide | CHRW | Apr 24, 2024 | 70.94 | +0.84 |
Cadence Design Systems | CDNS | Apr 24, 2024 | 277.66 | -1.46 |
Caesars Entertainment | CZR | Apr 24, 2024 | 38.48 | -1.64 |
Camden Property Trust | CPT | Apr 24, 2024 | 98.86 | +0.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.